Targeting XIAP for the treatment of malignancy

X-linked inhibitor of apoptosis protein (XIAP) is a member of the inhibitor of apoptosis proteins family of caspase inhibitors that selectively binds and inhibits caspases-3, -7 and -9, but not caspase-8. As such, XIAP blocks a substantial portion of the apoptosis pathway and is an attractive target for novel therapeutic agents for the treatment of malignancy. Antisense oligonucleotides directed against XIAP are effective in vitro and are currently being evaluated in clinical trials. Small molecule XIAP inhibitors that target the baculovirus IAP repeat (BIR) 2 or BIR 3 domain are in preclinical development and are advancing toward the clinic. This review will discuss the progress being made in developing antisense and small-molecule XIAP inhibitors.

[1]  V. Dixit,et al.  Reversible Contraception like Activity of Embelin in Male Dogs (Canis indicus Linn) , 2009, Andrologia.

[2]  S. Sharma,et al.  Toxicity studies with potassium embelate, a new analgesic compound. , 1990, Indian journal of experimental biology.

[3]  E. Sukumar,et al.  Antitumor, anti-inflammatory and analgesic property of embelin, a plant product. , 1994, Chemotherapy.

[4]  C. Thompson,et al.  A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. , 1996, The EMBO journal.

[5]  D. Altieri,et al.  A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.

[6]  C. Thompson,et al.  Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J C Reed,et al.  IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases , 1998, The EMBO journal.

[8]  R van Driel,et al.  Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J C Reed,et al.  Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases , 1999, The EMBO journal.

[10]  A. Fraser,et al.  Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis , 1999, Current Biology.

[11]  Stephen W. Fesik,et al.  NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP , 1999, Nature.

[12]  Xiaodong Wang,et al.  Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.

[13]  Geng Wu,et al.  Structural basis of IAP recognition by Smac/DIABLO , 2000, Nature.

[14]  Stephen W. Fesik,et al.  NMR Structure and Mutagenesis of the Third Bir Domain of the Inhibitor of Apoptosis Protein XIAP* , 2000, The Journal of Biological Chemistry.

[15]  Robert L Moritz,et al.  Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins , 2000, Cell.

[16]  T. Chow,et al.  Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death , 2000, Oncogene.

[17]  Yili Yang,et al.  Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. , 2000, Science.

[18]  Stephen F. Betz,et al.  Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain , 2000, Nature.

[19]  Christian Stehlik,et al.  Activation of NF-κB by XIAP, the X Chromosome-linked Inhibitor of Apoptosis, in Endothelial Cells Involves TAK1* , 2000, The Journal of Biological Chemistry.

[20]  Y. Sheng,et al.  Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. , 2000, Cancer research.

[21]  G. Giaccone,et al.  Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  Stephanie Birkey Reffey,et al.  Characterization of XIAP-Deficient Mice , 2001, Molecular and Cellular Biology.

[23]  S. Srinivasula,et al.  Structural Basis of Caspase-7 Inhibition by XIAP , 2001, Cell.

[24]  Emad S. Alnemri,et al.  A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis , 2001, Nature.

[25]  John Calvin Reed,et al.  X-linked Inhibitor of Apoptosis Protein (XIAP) Inhibits Caspase-3 and -7 in Distinct Modes* , 2001, The Journal of Biological Chemistry.

[26]  Young Chul Park,et al.  Structural Basis of Caspase Inhibition by XIAP Differential Roles of the Linker versus the BIR Domain , 2001, Cell.

[27]  A. Cheung,et al.  Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma. , 2001, European journal of cancer.

[28]  R. Liddington,et al.  Structural Basis for the Inhibition of Caspase-3 by XIAP , 2001, Cell.

[29]  H. Nakayama,et al.  A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. , 2001, Molecular cell.

[30]  R. Götz,et al.  Neurotrophin Receptor-interacting Mage Homologue Is an Inducible Inhibitor of Apoptosis Protein-interacting Protein That Augments Cell Death* , 2001, The Journal of Biological Chemistry.

[31]  R. Takahashi,et al.  Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Breithardt,et al.  xIAP Induces Cell-Cycle Arrest and Activates Nuclear Factor-&kgr;B: New Survival Pathways Disabled by Caspase-Mediated Cleavage During Apoptosis of Human Endothelial Cells , 2001, Circulation research.

[33]  G. Gores,et al.  Synthetic Smac/DIABLO Peptides Enhance the Effects of Chemotherapeutic Agents by Binding XIAP and cIAP1 in Situ * , 2002, The Journal of Biological Chemistry.

[34]  Michael Weller,et al.  Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo , 2002, Nature Medicine.

[35]  G M Cohen,et al.  XIAP inhibition of caspase-3 preserves its association with the Apaf-1 apoptosome and prevents CD95- and Bax-induced apoptosis , 2002, Cell Death and Differentiation.

[36]  Deqi Chen,et al.  High-throughput virtual screening for drug discovery in parallel. , 2002, Current opinion in drug discovery & development.

[37]  C. Martínez-A,et al.  GH3, a novel proapoptotic domain in Drosophila Grim, promotes a mitochondrial death pathway , 2002, The EMBO journal.

[38]  R. Moritz,et al.  HtrA2 Promotes Cell Death through Its Serine Protease Activity and Its Ability to Antagonize Inhibitor of Apoptosis Proteins* , 2002, The Journal of Biological Chemistry.

[39]  Jongdae Lee,et al.  IAP Suppression of Apoptosis Involves Distinct Mechanisms: the TAK1/JNK1 Signaling Cascade and Caspase Inhibition , 2002, Molecular and Cellular Biology.

[40]  Yahong Lin,et al.  A JNK-Dependent Pathway Is Required for TNFα-Induced Apoptosis , 2003, Cell.

[41]  S. Srinivasula,et al.  Mechanism of XIAP-mediated inhibition of caspase-9. , 2003, Molecular cell.

[42]  John Calvin Reed,et al.  Identification of ubiquitination sites on the X-linked inhibitor of apoptosis protein. , 2003, The Biochemical journal.

[43]  P. Schultz,et al.  Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction. , 2003, Chemistry & biology.

[44]  R. Rich,et al.  Requirement of Both the Second and Third BIR Domains for the Relief of X-linked Inhibitor of Apoptosis Protein (XIAP)-mediated Caspase Inhibition by Smac* , 2003, Journal of Biological Chemistry.

[45]  Yahong Lin,et al.  A JNK-dependent pathway is required for TNFalpha-induced apoptosis. , 2003, Cell.

[46]  D. Altieri.  Survivin, versatile modulation of cell division and apoptosis in cancer , 2003, Oncogene.

[47]  H. Sung,et al.  Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis. , 2003, Blood.

[48]  V. Dragowska,et al.  Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[49]  Takashi Tsuruo,et al.  Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. , 2003, Cancer research.

[50]  Xiaodong Wang,et al.  A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death , 2004, Science.

[51]  T. Haferlach,et al.  XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis. , 2004, The hematology journal : the official journal of the European Haematology Association.

[52]  Clemencia Pinilla,et al.  Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. , 2004, Cancer cell.

[53]  Stephanie Birkey Reffey,et al.  Uncoupling of the Signaling and Caspase-inhibitory Properties of X-linked Inhibitor of Apoptosis* , 2004, Journal of Biological Chemistry.

[54]  C. Wijmenga,et al.  A novel role for XIAP in copper homeostasis through regulation of MURR1 , 2004, The EMBO journal.

[55]  Shaomeng Wang,et al.  Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site. , 2004, Journal of medicinal chemistry.

[56]  Xiaodong Wang,et al.  A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. , 2004, Science.

[57]  Clemencia Pinilla,et al.  Cellular, Biochemical, and Genetic Analysis of Mechanism of Small Molecule IAP Inhibitors* , 2004, Journal of Biological Chemistry.

[58]  Yigong Shi.  Caspase activation, inhibition, and reactivation: A mechanistic view , 2004, Protein science : a publication of the Protein Society.

[59]  E. Borden,et al.  Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis , 2004, Cell Death and Differentiation.

[60]  J. C. Wilkinson,et al.  Upstream Regulatory Role for XIAP in Receptor-Mediated Apoptosis , 2004, Molecular and Cellular Biology.

[61]  C. Morrissey,et al.  An antisense oligonucleotide to cIAP‐1 sensitizes prostate cancer cells to fas and TNFα mediated apoptosis , 2004, The Prostate.

[62]  S. Agrawal,et al.  Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics , 2004, Oncogene.

[63]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[64]  J. Harbott,et al.  High Expression Levels of X-Linked Inhibitor of Apoptosis Protein and Survivin Correlate with Poor Overall Survival in Childhood de Novo Acute Myeloid Leukemia , 2004, Clinical Cancer Research.

[65]  P. Iversen,et al.  X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. , 2004, Molecular Cancer Therapeutics.

[66]  Dajun Yang,et al.  Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. , 2004 .

[67]  Saul H Rosenberg,et al.  Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. , 2004, Journal of medicinal chemistry.

[68]  Shaomeng Wang,et al.  Structure-based design of potent, conformationally constrained Smac mimetics. , 2004, Journal of the American Chemical Society.

[69]  A. Schimmer.  Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice , 2004, Cancer Research.

[70]  G. Salvesen,et al.  XIAP inhibits caspase‐3 and ‐7 using two binding sites: evolutionarily conserved mechanism of IAPs , 2005, The EMBO journal.

[71]  Q. Tong,et al.  Downregulation of XIAP expression induces apoptosis and enhances chemotherapeutic sensitivity in human gastric cancer cells , 2005, Cancer Gene Therapy.

[72]  P. Smolewski,et al.  The inhibitor of apoptosis protein family and its antagonists in acute leukemias , 2004, Apoptosis.

[73]  Shaomeng Wang,et al.  Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimetics. , 2005, Bioorganic & Medicinal Chemistry Letters.

[74]  N. Zaffaroni,et al.  Survivin as a target for new anticancer interventions , 2005, Journal of cellular and molecular medicine.

[75]  R. Honda,et al.  X-linked inhibitor of apoptosis functions as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO. , 2005, Journal of biochemistry.

[76]  John Calvin Reed,et al.  Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. , 2005, Cancer research.

[77]  M. Ranson,et al.  Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP , 2005, British Journal of Cancer.